Grants and Contributions:
Title:
CDMO Biologics Development and Manufacturing operation
Agreement Number:
819623
Agreement Value:
$22,439,200.00
Agreement Date:
Jan 4, 2023 - Jan 1, 2046
Description:
This project will support the establishment of a biomanufacturing and development facility that is focused on mammalian cell culture. The facility will manufacture and produce antibody-based therapeutics and other protein biologics.
Organization:
Innovation, Science and Economic Development Canada
Expected Results:
The project will strengthen Canada's response to COVID-19 and build Canada's long term emergency preparedness. The facility will enhance Canada’s biomanufacturing capacity, support pre-clinical needs, clinical trials and meet commercial requirements.
Location:
Mississauga, Ontario, CA L5K1B3
Reference Number:
033-2023-2024-Q4-819623
Agreement Type:
Other transfer payment
Report Type:
Grants and Contributions
Recipient Business Number:
879299600
Recipient Type:
For-profit organization
Additional Information:
This is a partially repayable contribution.
Recipient's Operating Name:
Eurofins CDMO Alphora Inc.
Recipient's Legal Name:
Eurofins CDMO Alphora Inc.
Federal Riding Name:
Mississauga--Lakeshore
Federal Riding Number:
35061
Program:
SIF Stream2- Growth
Program Purpose:
-Encourage R&D that will accelerate technology transfer and commercialization of innovative products, processes and services;-Facilitate the growth and expansion of firms in Canada;-Attract and retain large scale investments to Canada; and-Advance industrial research, development and technology demonstration through collaboration between academia, non-profit organizations and the private sector.
NAICS Code:
339900